These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 16198649)
21. Murine Oatp1a/1b uptake transporters control rosuvastatin systemic exposure without affecting its apparent liver exposure. Iusuf D; van Esch A; Hobbs M; Taylor M; Kenworthy KE; van de Steeg E; Wagenaar E; Schinkel AH Mol Pharmacol; 2013 May; 83(5):919-29. PubMed ID: 23429889 [TBL] [Abstract][Full Text] [Related]
22. ABCB1 gene polymorphisms, ABCB1 haplotypes and ABCG2 c.421c > A are determinants of inter-subject variability in rosuvastatin pharmacokinetics. Zhou Q; Ruan ZR; Yuan H; Xu DH; Zeng S Pharmazie; 2013 Feb; 68(2):129-34. PubMed ID: 23469685 [TBL] [Abstract][Full Text] [Related]
23. Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States. Birmingham BK; Bujac SR; Elsby R; Azumaya CT; Zalikowski J; Chen Y; Kim K; Ambrose HJ Eur J Clin Pharmacol; 2015 Mar; 71(3):329-40. PubMed ID: 25630984 [TBL] [Abstract][Full Text] [Related]
24. Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect? Birmingham BK; Bujac SR; Elsby R; Azumaya CT; Wei C; Chen Y; Mosqueda-Garcia R; Ambrose HJ Eur J Clin Pharmacol; 2015 Mar; 71(3):341-55. PubMed ID: 25673568 [TBL] [Abstract][Full Text] [Related]
25. Effects of statin treatments and polymorphisms in UGT1A1 and SLCO1B1 on serum bilirubin levels in Chinese patients with hypercholesterolaemia. Hu M; Tomlinson B Atherosclerosis; 2012 Aug; 223(2):427-32. PubMed ID: 22749334 [TBL] [Abstract][Full Text] [Related]
26. Personalised medicine: who is an Asian? Po ALW Lancet; 2007 May; 369(9575):1770-1771. PubMed ID: 17531869 [No Abstract] [Full Text] [Related]
27. Effects of polymorphisms in ABCG2, SLCO1B1, SLC10A1 and CYP2C9/19 on plasma concentrations of rosuvastatin and lipid response in Chinese patients. Lee HK; Hu M; Lui SSh; Ho CS; Wong CK; Tomlinson B Pharmacogenomics; 2013 Aug; 14(11):1283-94. PubMed ID: 23930675 [TBL] [Abstract][Full Text] [Related]
28. [Pharmacogenomics: inter-ethnic and intra-ethnic differences in pharmacokinetic and pharmacodynamic profiles of clinically relevant drugs]. Ieiri I; Higuchi S Yakugaku Zasshi; 2009 Feb; 129(2):231-5. PubMed ID: 19182452 [TBL] [Abstract][Full Text] [Related]
29. The effect of Na+/taurocholate cotransporting polypeptide (NTCP) c.800C > T polymorphism on rosuvastatin pharmacokinetics in Chinese healthy males. Lou XY; Zhang W; Wang G; Hu DL; Guo D; Tan ZR; Zhou HH; Chen Y; Bao HH Pharmazie; 2014 Oct; 69(10):775-9. PubMed ID: 25985569 [TBL] [Abstract][Full Text] [Related]
30. Treatment and prevention of dyslipidemia with rosuvastatin (Crestor). Leonard KA Nurse Pract; 2004 May; 29(5):11-5. PubMed ID: 15167530 [No Abstract] [Full Text] [Related]
31. Race differences: modeling the pharmacodynamics of rosuvastatin in Western and Asian hypercholesterolemia patients. Yang J; Li LJ; Wang K; He YC; Sheng YC; Xu L; Huang XH; Guo F; Zheng QS Acta Pharmacol Sin; 2011 Jan; 32(1):116-25. PubMed ID: 21151159 [TBL] [Abstract][Full Text] [Related]
32. Rosuvastatin is transferred into human breast milk: a case report. Schutte AE; Symington EA; du Preez JL Am J Med; 2013 Sep; 126(9):e7-8. PubMed ID: 23968910 [No Abstract] [Full Text] [Related]
33. Pharmacokinetic properties of rosuvastatin after single-dose, oral administration in Chinese volunteers: a randomized, open-label, three-way crossover study. Li Y; Jiang X; Lan K; Zhang R; Li X; Jiang Q Clin Ther; 2007 Oct; 29(10):2194-203. PubMed ID: 18042475 [TBL] [Abstract][Full Text] [Related]
34. Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin. Kitamura S; Maeda K; Wang Y; Sugiyama Y Drug Metab Dispos; 2008 Oct; 36(10):2014-23. PubMed ID: 18617601 [TBL] [Abstract][Full Text] [Related]
35. Enterohepatic disposition of rosuvastatin in pigs and the impact of concomitant dosing with cyclosporine and gemfibrozil. Bergman E; Lundahl A; Fridblom P; Hedeland M; Bondesson U; Knutson L; Lennernäs H Drug Metab Dispos; 2009 Dec; 37(12):2349-58. PubMed ID: 19773540 [TBL] [Abstract][Full Text] [Related]
36. The effect of gemfibrozil on the pharmacokinetics of rosuvastatin. Schneck DW; Birmingham BK; Zalikowski JA; Mitchell PD; Wang Y; Martin PD; Lasseter KC; Brown CD; Windass AS; Raza A Clin Pharmacol Ther; 2004 May; 75(5):455-63. PubMed ID: 15116058 [TBL] [Abstract][Full Text] [Related]
37. Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males. Zhang W; Yu BN; He YJ; Fan L; Li Q; Liu ZQ; Wang A; Liu YL; Tan ZR; Fen-Jiang ; Huang YF; Zhou HH Clin Chim Acta; 2006 Nov; 373(1-2):99-103. PubMed ID: 16784736 [TBL] [Abstract][Full Text] [Related]
38. Transepithelial transport of rosuvastatin and effect of ursolic acid on its transport in Caco-2 monolayers. Hua WJ; Fang HJ; Hua WX Eur J Drug Metab Pharmacokinet; 2012 Sep; 37(3):225-31. PubMed ID: 22562361 [TBL] [Abstract][Full Text] [Related]
39. The contribution of organic anion transporters OAT1 and OAT3 to the renal uptake of rosuvastatin. Windass AS; Lowes S; Wang Y; Brown CD J Pharmacol Exp Ther; 2007 Sep; 322(3):1221-7. PubMed ID: 17585018 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of rosuvastatin in healthy Chinese volunteers living in China: a randomized, open-label, ascending single- and multiple-dose study. Li XN; Xu HR; Chen WL; Chu NN; Zhu JR Clin Ther; 2010 Mar; 32(3):575-87. PubMed ID: 20399994 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]